company background image
3737 logo

Zhongzhi Pharmaceutical Holdings SEHK:3737 Stock Report

Last Price

HK$1.21

Market Cap

HK$984.5m

7D

10.0%

1Y

6.1%

Updated

23 Jul, 2024

Data

Company Financials

Zhongzhi Pharmaceutical Holdings Limited

SEHK:3737 Stock Report

Market Cap: HK$984.5m

3737 Stock Overview

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.

3737 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends2/6

Zhongzhi Pharmaceutical Holdings Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhongzhi Pharmaceutical Holdings
Historical stock prices
Current Share PriceHK$1.21
52 Week HighHK$1.56
52 Week LowHK$0.94
Beta0.56
11 Month Change1.68%
3 Month Change-0.82%
1 Year Change6.14%
33 Year Change-5.47%
5 Year Change-7.63%
Change since IPO-49.37%

Recent News & Updates

Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Jun 19
Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

May 10
Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

Recent updates

Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Jun 19
Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

May 10
Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

May 05
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

Feb 01
Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

May 24
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Aug 26
Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

Apr 28
Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

May 06
Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

Mar 29
Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Mar 05
The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 15
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Jan 14
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

Dec 27
Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Dec 14
If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Nov 30
Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 17
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Shareholder Returns

3737HK PharmaceuticalsHK Market
7D10.0%2.9%-2.9%
1Y6.1%-2.9%1.1%

Return vs Industry: 3737 exceeded the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.

Return vs Market: 3737 exceeded the Hong Kong Market which returned 1.1% over the past year.

Price Volatility

Is 3737's price volatile compared to industry and market?
3737 volatility
3737 Average Weekly Movement6.6%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement6.8%
10% most volatile stocks in HK Market14.5%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 3737 has not had significant price volatility in the past 3 months.

Volatility Over Time: 3737's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19932,643Ying Feng Laiwww.zeus.cn

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands.

Zhongzhi Pharmaceutical Holdings Limited Fundamentals Summary

How do Zhongzhi Pharmaceutical Holdings's earnings and revenue compare to its market cap?
3737 fundamental statistics
Market capHK$984.50m
Earnings (TTM)HK$174.70m
Revenue (TTM)HK$2.20b

6.0x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3737 income statement (TTM)
RevenueCN¥2.05b
Cost of RevenueCN¥835.21m
Gross ProfitCN¥1.21b
Other ExpensesCN¥1.05b
EarningsCN¥162.78m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.19
Gross Margin59.25%
Net Profit Margin7.94%
Debt/Equity Ratio4.7%

How did 3737 perform over the long term?

See historical performance and comparison

Dividends

4.9%

Current Dividend Yield

43%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.